千珍品牌怎么样 申请店铺

我要投票 千珍在医疗器械行业中的票数:555 更新时间:2026-01-03
千珍是哪个国家的品牌?「千珍」是 广西千珍制药有限公司 旗下著名品牌。该品牌发源于广西南宁市,由创始人余平德在2004-06-18期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力千珍品牌出海!将品牌入驻外推网,定制千珍品牌推广信息,可以显著提高千珍产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

千珍怎么样

千珍(长安)制药是一个集天然药物研发、中药提取、生产、营销于一体的综合性现代化制药企业,公司总部位于国家第四个经济区北部湾核心城市南宁,目前拥有千珍制药(位于南宁)、长安制药(位于柳州融安县)两个具规模的中药现代化生产基地,其药品生产有40年历史,厂区按GMP标准设计建造,以绿色生态环境生产为标准,已建成中药提取、颗粒剂、片剂、胶囊剂、口服液、糖浆剂、酊剂、煎膏剂等生产基地。

千珍牌系列产品以治疗百姓家庭常见病为主体,拥有感冒止咳类、儿童类以及综合类等系列产品。系列产品分布感冒止咳良药的感冒止咳糖浆、止咳枇杷糖浆、川贝枇杷糖浆、二冬膏、板蓝根颗粒(无糖型)、蛇胆川贝液等产品;儿童专用药的山楂麦曲颗粒儿童装、小儿复方麻黄碱桔梗糖浆、大山楂颗粒儿童装、小儿化痰止咳颗粒等治疗儿童常见的消化不良、感冒咳嗽等症状;综合类产品拥有复方罗汉果止咳片、参芪首乌补汁、罗汉果玉竹颗粒、维C银翘片(薄膜衣片)、牛黄上清片、消炎利胆片、消炎片(薄膜衣片)等家庭日常用药。

千珍(长安)制药高度注重研发创新,公司在南宁设有产品研发中心,并与中国科学院上海药物研究所、韩国Chemizon药业技术公司等国内外专业药物研究机构结成的战略合作伙伴追随国家对中医民族药的开发与重视,千珍(长安)制药2009年整合资源以新形象面市,公司董事会决策推出“千珍品牌运作工程”——决心做老百姓心中的品牌药,对产品生产技术、产品用料、产品包装进行提升。


Qianzhen (Chang'an) Pharmaceutical Co., Ltd. is a comprehensive modern pharmaceutical enterprise integrating natural drug research and development, Chinese medicine extraction, production and marketing. Its headquarter is located in Nanning, the core city of Beibu Gulf, the fourth economic zone of China. At present, it has two large-scale modern production bases of Chinese medicine, qianzhen (Nanning) and Chang'an (Rongan County, Liuzhou) It has a history of 40 years. The factory is designed and built according to GMP standard, taking the production of green ecological environment as the standard, and has established the production bases of traditional Chinese medicine extraction, granules, tablets, capsules, oral liquids, syrups, tinctures, decoctions, etc. Qianzhen brand series products take the treatment of common diseases of common people's families as the main body, with cold and cough relief, children's and comprehensive series products. The series of products are mainly distributed in cold cough syrup, cough loquat syrup, Chuanbei loquat syrup, Erdong cream, Banlangen Granules (sugar free type), Hedan Chuanbei liquid and other products; children's special medicines such as hawthorn maiqu granules children's clothing, children's Compound Ephedrine and Platycodon syrup, big Hawthorn granules children's clothing, children's Huatan Zhike granules and other products to treat children's common dyspepsia Symptoms such as cold and cough; comprehensive products include compound Luohanguo cough tablet, shenqishouwu Buzhi, Luohanguo Yuzhu granules, vitamin C Yinqiao tablet (film coated tablet), Niuhuang Shangqing tablet, Xiaoyan Lidan tablet, Xiaoyan tablet (film coated tablet) and other household daily drugs. Qianzhen (Chang'an) pharmaceutical attaches great importance to R & D and innovation. The company has a product R & D center in Nanning, and strategic partners with Shanghai Pharmaceutical Research Institute of Chinese Academy of Sciences, Chemizon pharmaceutical technology company of South Korea and other professional pharmaceutical research institutions at home and abroad follow the country's development and attention to traditional Chinese medicine. In 2009, qianzhen (Chang'an) pharmaceutical integrated resources and launched a new image, The board of directors of the company decided to launch the "qianzhen brand operation project" - determined to be the brand medicine in the hearts of the common people, and improve the production technology, product materials and product packaging.

本文链接: https://brand.waitui.com/9fc58e1a7.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

印度政府批准电子元件制造计划下的投资金额为4186.3亿卢比

印度政府批准电子元件制造计划下的投资金额为4186.3亿卢比。(财联社)

2小时前

分析师:三星SDI或将持续亏损直至2026年底

NH Investment & Securities以Ju Min-woo为首的分析师表示,三星SDI在2025年第四财季因美国电动汽车需求疲软而录得大于预期的亏损后,可能会持续亏损直至2026年底。这些分析师表示,由于在欧洲的电动汽车电池市场份额不断下滑,这家韩国电池制造商可能比竞争对手受到更大冲击。NH Investment & Securities预计,该公司第四财季将录得3,387亿韩元的营业亏损,而市场平均预期为亏损2,690亿韩元,并预计其2025年年度亏损为1.765万亿韩元。NH Investment & Securities预测,该公司2026年的营业亏损可能收窄至9,670亿韩元。(新浪财经)

2小时前

葡萄牙12月特斯拉新车注册量同比下降12.7%,2025年累计下降22.3%

据葡萄牙汽车协会(ACAP),葡萄牙12月特斯拉新车注册量同比下降12.7%,2025年累计下降22.3%。(财联社)

2小时前

元旦假期首日,全社会跨区域人员流动量超2亿人次

2026年1月1日,全社会跨区域人员流动量20747.5万人次,环比下降0.1%,同比增长20.3%。(央视新闻)

2小时前

挪威2025年新车销量的96%为电动汽车

上周五的官方数据显示,去年在挪威注册的几乎所有新车都是纯电动汽车,其中特斯拉的销量更是一路飙升,使这个北欧国家在逐步淘汰汽油和柴油动力汽车方面巩固了全球领先地位。在税收优惠政策的推动下,2025年注册的所有新车中有95.9%是电动汽车,12月份这一数字接近98%。挪威道路联合会(OFV)的数据显示,这一年度数字高于2024年的88.9%。OFV称,挪威今年登记的新车数量达到创纪录的179549辆,比2024年增长了40%。(新浪财经)

2小时前

本页详细列出关于千珍的品牌信息,含品牌所属公司介绍,千珍所处行业的品牌地位及优势。
咨询